EMILY GILBERT: Open Payments
NPI 1376091116 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 71 payments from 30 companies in 2025. Trend: 2023 $2,316 · 2024 $1,641 · 2025 $1,610
Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $121 |
| Ipsen Biopharmaceuticals, Inc | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| ABBVIE INC. | 5 | $110 |
| PFIZER INC. | 5 | $102 |
| Daiichi Sankyo Inc. | 3 | $81 |
| Genentech USA, Inc. | 3 | $71 |
| Eisai Inc. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
Products named: LYNPARZA, Onivyde, Enhertu, Nubeqa, Lenvima, OJJAARA, KEYTRUDA, CALQUENCE.
Industry payments across VA — which companies pay providers there.
